Doctor profile · Federal record
Dr. JAMES ANTHONY, MD
Pulmonary Disease Physician (CMS: PULMONARY DISEASE) · Internal Medicine Physician · Critical Care Medicine (Internal Medicine) Physician · Critical Care Medicine (Internal Medicine) Physician · Pulmonary Disease Physician · VALPARAISO, IN
- NPI 1639356025
- Accepts Medicare
- MIPS 87.0 / 100 · 2023
- 28 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1101 GLENDALE BLVD, SUITE 103
VALPARAISO, IN 463833767
(219) 464-9054
fax (219) 465-1749
Credentials & registration
- NPI registered
- January 2008 — 18 yrs on file
- Profile last updated
- September 10, 2020
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State licenses (2)
- Indiana #01071016A · Illinois #036.125048
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1639356025. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,450
Distinct HCPCS
10
Medicare allowed
$230,247
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 1,022 | 254 | $75 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 509 | 180 | $112 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 225 | 184 | $85 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 180 | 165 | $163 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 178 | 134 | $119 | |
94060 |
Test to measure expiratory airflow and volume changes before and after medication administration | 47 | 46 | $10 | |
94726 |
Test to determine lung volumes using sensors | 47 | 46 | $11 | |
94729 |
Test to examine how well the lungs exchange gases | 47 | 46 | $8 | |
99291 |
Critical care, first 30-74 minutes | 41 | 37 | $198 | |
99239 |
Hospital discharge day management, more than 30 minutes | 36 | 35 | $109 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 153. This provider delivers 16× the peer median.Open Payments
Industry payments received
All-time total
$781
Transactions
27
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Boston Scientific Corporation | 1 | $146.43 | |
| Regeneron Healthcare Solutions, Inc. | 3 | $110.61 | |
| Inspire Medical Systems, Inc. | 2 | $76.85 | |
| ABBVIE INC. | 3 | $73.64 | |
| GENZYME CORPORATION | 3 | $67.42 | |
| Mallinckrodt Hospital Products Inc. | 2 | $56.79 | |
| GlaxoSmithKline, LLC. | 3 | $53.63 | |
| AstraZeneca Pharmaceuticals LP | 2 | $39.95 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36.04 | |
| Mylan Specialty L.P. | 2 | $28.99 | |
| Amgen Inc. | 1 | $28.75 | |
| Baxter Healthcare | 1 | $24.35 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22.59 | |
| Electromed, Inc. | 1 | $14.99 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,187
Patients
670
Total drug cost
$748,073
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 407 | 125 | $14,312 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 375 | 102 | $380,234 |
| Prednisone | Generic | 266 | 77 | $1,263 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 190 | 47 | $113,912 |
| Montelukast Sodium | Generic | 145 | 55 | $2,884 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 126 | 29 | $58,030 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 99 | 22 | $74,326 |
| Doxycycline Hyclate | Generic | 91 | 58 | $1,244 |
| Azithromycin | Generic | 88 | 35 | $1,362 |
| Wixela Inhub (Fluticasone Propion/Salmeterol) | Brand | 82 | 23 | $23,491 |